IPP Bureau
Sun Pharma introduces treatment for plaque psoriasis in Canada
By IPP Bureau - October 28, 2021
Moderate-to-severe plaque psoriasis affects about 35 per cent of patients. A key challenge is that many treatments stop working overtime and symptoms return
Cipla consolidated net profit at Rs 711.36 cr. in Q2FY22
By IPP Bureau - October 27, 2021
Cipla has reported consolidated financial results for the period ended September 30, 2021
Torrent Pharma consolidated PAT at Rs 316 cr. in Q2FY22
By IPP Bureau - October 27, 2021
Torrent Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
Sanofi India PAT at Rs. 529.8 cr in Q3CY21
By IPP Bureau - October 27, 2021
The Board of Directors of Sanofi India Limited, at its meeting held on October 26th 2021 have approved the unaudited Standalone financial results of the company for the period ended September 30, 2021
WHO selects Medigen’s Covid-19 vaccine for solidarity trial
By IPP Bureau - October 27, 2021
Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial
Dr Lal PathLabs to acquire Suburban Diagnostics for Rs 925 crore
By IPP Bureau - October 27, 2021
Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21
4baseCare partners with U.S. based Cellworks for personalised cancer care
By IPP Bureau - October 27, 2021
The collaboration aims to deliver greater insights to the oncology fraternity, predict patient therapy responses and enable therapy selection resulting in optimal treatment outcomes.
Medwiki’s online video library aims to help understand medicines better
By IPP Bureau - October 27, 2021
It answers the most basic questions from a patient’s perspective
PLI scheme has the potential to make India a pharma hub: Dr Mandaviya
By IPP Bureau - October 27, 2021
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Novavax files for approval of its Covid-19 vaccine in the UK
By IPP Bureau - October 27, 2021
Filing marks first protein-based vaccine submitted to MHRA for authorization
NPPA fixes ceiling price for anti-diabetic generic medicines
By IPP Bureau - October 26, 2021
A total of 12 generic medicines have been included in the list
Biological E to receive US $ 50 million to boost Covid-19 vaccine capacity
By IPP Bureau - October 26, 2021
Support from DFC will help produce one billion vaccine doses by the end of 2022
Apollo Hospitals announces free Covid-19 vaccines to kids with co-morbidities
By IPP Bureau - October 26, 2021
The list of kids with co-morbidities eligible for vaccination would be announced by the government
PM launches PM Ayushman Bharat Health Infrastructure Mission
By IPP Bureau - October 26, 2021
Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country
ANG Life Sciences India H1FY22 consolidated PAT zooms to Rs. 33.77 crore
By IPP Bureau - October 26, 2021
ANG Lifesciences India Limited has reported financial results for the period ended September 30, 2021
